Examples
| Generic Name | Brand Name |
|---|
| rasagiline mesylate | Azilect |
| selegiline hydrochloride | Deprenyl, Eldepryl |
How It Works
Monoamine oxidase inhibitors (MAOIs) prolong the effects of
dopamine in the brain by preventing its breakdown.
They also may prevent the removal of dopamine between nerve endings and enhance
release of dopamine from nerve cells. Rasagiline and selegiline are selective
monoamine oxidase (MAO-B) inhibitors.
Why It Is Used
MAO-B inhibitors may be used in the early stages of
Parkinson's disease to treat very mild symptoms (such
as resting tremor) and delay the need for levodopa. However, they have minimal
effects when used alone, and better medications are available for this
purpose.
In people with advanced Parkinson's disease who are taking
levodopa, rasagiline or selegiline may be added to levodopa treatment to reduce
motor
fluctuations, increase the time of effect of the levodopa, and decrease
the amount of levodopa needed to control symptoms.1
How Well It Works
In the early stages of Parkinson's disease MAO-B inhibitors may
improve symptoms and can delay the need for levodopa. However, the benefits are
considered modest.2
When used with levodopa in people with advanced disease, rasagiline
or selegiline may reduce motor fluctuations and increase the length of “on”
periods (times when medication is able to control symptoms).1
Side Effects
When rasagiline or selegiline is used alone, it causes few side
effects in the doses that are used to treat Parkinson's disease. These
medicines can cause nausea, insomnia, and occasionally confusion and
hallucinations (seeing or hearing things that aren't really there). Insomnia
can be avoided by taking the last dose by midday so that its stimulant effect
will have declined before bedtime. Most people tolerate MAO-B inhibitors fairly
well.
Increased confusion and other cognitive side effects are more
likely to occur when MAO-B inhibitors are used in combination with levodopa,
especially in older people. Rasagiline and selegiline also can cause frequent
falls and should not be given to older people who have orthostatic hypotension
(low blood pressure when a person stands up).
Certain risk-taking behavior, like uncontrollable gambling and
shopping, has been linked to medicines used to treat Parkinson's disease. It
seems that these behaviors may occur more often in patients taking MAO-B
inhibitors in addition to levodopa.
It may be dangerous to take MAO-B inhibitors with antidepressants,
including both selective serotonin reuptake inhibitors (SSRIs, such as
fluoxetine [Prozac] or sertraline [Zoloft]) and tricyclic antidepressants (such
as amitriptyline [for example, Elavil] or protriptyline [Vivactil]).
Unlike other drugs in the monoamine oxidase inhibitor (MAOI) class,
rasagiline and selegiline are not thought to cause high blood pressure when
taken in combination with alcohol (wine, beer, or sherry) or certain foods,
including cheddar and aged cheeses, avocados, bananas, liver, miso, pickled
herring, and yeast extract. However, if you experience a severe headache or
chest pain while taking rasagiline or selegiline, you should seek medical care
immediately.
See Drug Reference for a full list of side effects. (Drug Reference
is not available in all systems.)
What To Think About
MAO-B inhibitors have a mild effect on the relief of Parkinson's
disease symptoms when used alone. A greater effect is seen when they are used
in combination with levodopa.
Experts continue to debate whether rasagiline and selegiline may
protect dopamine-producing nerves in the brain and slow the progression of the
disease. Although some studies suggest that rasagiline and selegiline may help
to slow the progression of Parkinson's disease, they are currently being used
only to treat symptoms of the disease.
Complete the
new medication information form (PDF)
(What is a PDF document?)
to help you understand this medication.